Transplant Monitoring Kits Market - Top Companies and Manufacturers

  • Report ID: 5918
  • Published Date: Mar 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Transplant Monitoring Kits Landscape

top-features-companies
    • CareDx Inc.
    • Company Overview
    • Business Planning
    • Main Product Offerings
    • Financial Execution
    • Main Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Thermo Fisher Scientific
    • QIAGEN
    • Hologic
    • Eurofins Scientific
    • JETA Molecular
    • ELITech Group
    • Natera Inc.
    • Roche Ltd.
    • Biocare Health Resources Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • CareDx, Inc., the transplant organization, declared that it will be demonstrating the breadth of its personalized digital solutions and the newest modifications in its cellular treatment and transplant monitoring pipeline at the 2024 Tandem Meetings, Transplantation& Cellular Therapy Meetings of ASTCT™ and CIBMTR®, organized on February 21- 25 in San Antonio, Texas.
  • CareDx, Inc., the transplant organization, declared a leading existence and the fifth successive year as the Distinguished Founder’s Circle Sponsor for the Annual American Society of Transplant Surgeons (ASTS) Winter Symposium organized on January 11 - 14, 2024 in Miami, Florida.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5918
  • Published Date: Mar 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising number of organ failures across the world will majorly drive the market growth of the transplant monitoring kits market.

The market size of the transplant monitoring kits market is expected to get a CAGR of approximately 5% over the forecast period, i.e., 2024-2036.

The major players in the market are CareDx Inc., Thermo Fisher Scientific, QIAGEN, Hologic, Eurofins Scientific, JETA Molecular, ELITech Group, Natera Inc., Roche Ltd., Biocare Health Resources Inc., Takeda Pharmaceutical Co Ltd., Astellas Pharma Inc., Otsuka Holdings Co Ltd., Eisai Co Ltd.

The reagents & consumables segment is anticipated to reap the largest market size with almost 43% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying